Community/Retail

Farah Towfic, PharmD, MBA, RPh, director, CEO Operations, US Pharmacopeia, discusses some of the primary topics impacting pharmacists’ delivery of care and quality this year.

Ideally, older patients receive vaccinations by October, but disease activity often peaks in February or March.

Results of the ACTIV-6 study showed that high dose ivermectin use did not demonstrate a clinical benefit for mild to moderate COVID-19.

Products range from Parkinson disease treatment to medication for epilepsy.

Cognitive performance was higher if a person maintained physical activity throughout their lifetime.

Increasing interventions for affordable housing and food security could contribute to reduced rates of heart disease in lower income communities.

If approved, the vaccine would be the first immunization for use in pregnant individuals to help protect against the complications of respiratory syncytial virus in infants from birth through 6 months.

Including the ThinPrep Pap Test improves access to the benefits of the human papillomavirus (HPV) assay, which is the only FDA-approved assay that tests for an extended set of HPV types individually.

In a subgroup analysis, patients with COVID-19 who received conventional oxygen support also benefitted, having 20 fewer deaths per 1000 patients when given remdesivir.

Products include medications for depressive disorder and migraines.

Autoimmune diseases are often chronic conditions that can evolve, so minimizing damage and progression is typically the mainstay of treatment.

Sparsentan decreased proteinuria by nearly 50% in patients with IgA nephropathy, which may slow kidney function decline.

Case studies highlight questions about shingles.

New research from Harvard Medical School could be a game changer for the management of headaches associated with anti-CGRP migraine therapy.

With recent outbreaks of measles and other vaccine-preventable diseases, vaccinations are more important than ever.

Ronna Hauser of the National Community Pharmacists Association discusses how pharmacists should prepare for DIR fee changes with guests from NCPA.

One of the major concerns about getting a flu vaccine is its safety for women during pregnancy.

In addition to vital historical contributions, pharmacists of color are crucial in reaching marginalized communities and providing culturally competent care.

Managing understaffing and increasingly demanding workflows is an ongoing challenge in pharmacy.

The approval marks the first and only treatment for geographic atrophy, a leading cause of blindness.

Findings highlight the need for evidence-based strategies to avoid being obese or overweight for patients with type 1 diabetes, which is often considered a disease of thin individuals.

Approximately 48.1% of those who received vaccines had family members or friends who were either sick or recovered from the illness compared with 26.9% who were unvaccinated.

The findings are the first to explain the mechanisms of any Kawasaki disease, a rare childhood inflammatory condition that is triggered by different viruses.

Austedo XR will be available in 3 extended-release tablet strengths, which provides an updated regimen that may result in a lower pill count for patients.

USP executive notes importance of including different voices, perspectives for expansion of quality medicine.

Antibodies from an original COVID-19 vaccination may treat the mRNA booster vaccine as a virus that needs to be cleared.

The latest data indicate that the formulation can provide up to 6 months of full protection against multiple virus challenges.

The risk of new-onset cardiometabolic diseases was significantly elevated post-COVID-19 infection compared to pre-COVID-19 infection.

Health care providers prescribe naloxone to 1 in every 70 patients prescribed a high-dose opioid medication.

Matt Gibbs, president of Capital Rx, discusses alternative career paths in independently owned PBMs.